2013 PROGRAM COMMITTEE

Kenneth L. Mattox, MD, FACS
Program Director
Distinguished Service Professor
Michael E. DeBakey Department of Surgery
Baylor College of Medicine
Chief of Staff & Chief of Surgery
Ben Taub General Hospital
Houston, TX

Norman E. McSwain, Jr., MD, FACS
Professor of Surgery
Tulane University Medical School
Trauma Director, Spirit of Charity Trauma Center, ILH
New Orleans, LA

Matthew J. Wall, Jr., MD, FACS
Professor, Michael E. DeBakey
Department of Surgery
Baylor College of Medicine
Chief, Thoracic Surgery
Ben Taub General Hospital
Houston, TX

Mary Allen
Program Coordinator
Administrative Associate
Michael E. DeBakey Department of Surgery
Baylor College of Medicine
Houston, TX

COURSE FACULTY

Hamad Amani, MD, FACS
Associate Medical Director
Lehigh Valley Regional Burn Center
Allentown, PA

Carlos V.R. Brown, MD, FACS
Associate Professor of Surgery
University of Texas Southwestern - Austin
Trauma Medical Director
University Medical Center - Brackenridge
Austin, TX

CAPT Miguel Cubano, MD, FACS
Deputy Director
Defense Medical Readiness Training Institute
Fort Sam Houston, TX

Christopher Colwell, MD, FACEP
Director Emergency Medical Services
Staff Physician
Denver Health Medical Center
Associate Professor
University of Colorado SCM
Denver, CO

Alexander L. Eastman, MD, MPH, FACS
Assistant Professor of Surgery
The University of Texas Southwestern Medical Center
Interim Medical Director, The Trauma Center
At Parkland Memorial Hospital
Lieutenant and Lead Medical Officer, Dallas Polilce Department
Dallas, TX

Col. James R. Ficke, MD
Chairman, Department of Orthopaedics & Rehabilitation
Orthopaedic Surgery Consultant
US Army Surgeon General
San Antonio Military Medical Center
Fort Sam Houston, TX

Kenneth L. Mattox, MD, FACS
Distinguished Service Professor
Michael E. DeBakey Department of Surgery
Baylor College of Medicine
Chief of Staff & Chief of Surgery
Ben Taub General Hospital
Houston, TX

Norman E. McSwain Jr., MD, FACS
Professor of Surgery
Tulane University Medical School
Medical Director, Prehospital Trauma Life Support (PHTLS)
New Orleans, LA

R. Todd Maxson, MD, FACS
Trauma Medical Director
Arkansas Children's Hospital
Arkansas Department of Health
Associate Professor, Surgery
University of Arkansas for Medical Services
Little Rock, AR

Michael F. Rotondo, MD, FACS
Chairman, Committee on Trauma
American College of Surgeons
Professor and Chairman, Department of Surgery
Director, Center for Excellence for Trauma
& Surgical Critical Care
The Brody School of Medicine
East Carolina University
Greenville, NC

Richard A. Sidwell, MD, FACS
Chair, Rural Trauma Team Development Course
American College of Surgeons
Trauma Surgeon, Iowa Methodist Medical Center
Des Moines, IA

Ronald M. Stewart, MD, FACS
Professor & Chairman
Department of Surgery
Jocelyn and Joe Straus Endowed Chair in Trauma Research
The University of Texas Health Science Center
San Antonio, TX

CDR Ha C. Tang, DPO, US Public Health Service
Adjunct Associate Clinical Professor
Dartmouth Medical School
Community/Family Medicine Department
Deputy Chief of Family Medicine
Tuba City Regional Health Care Corporation
USPHS Medical Category Applicant Placement Administrator
Tuba City, AZ

Sheldon H. Teperman, MD, FACS
Associates Professor of Surgery
Director of Trauma and Critical Care Services
Jacobi Medical Center
Bronx, NY

In order to comply with the ACCME's Updated Standards for Commercial Support, The American College of Surgeons, as the accredited provider for this meeting, has implemented a new disclosure process to ensure that anyone who is in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest as it pertains to the content of the presentation. The ACCME defines a "commercial interest" as any proprietary entity producing health care goods or services consumed by, or used on patients. It does not consider providers of clinical service directly to patients to be commercial interests.

The ACS considers "relevant" financial relationships as financial transactions (in any amount) occurring within the past 12 months that may create a conflict of interest. The updated standards also require that ACS manage any reported conflict and eliminate the potential for bias during the session. The planning committee members (if applicable) and speakers were contacted and the conflicts listed below have been managed to our satisfaction. However, if you perceive a bias, please advise us of the circumstances on the evaluation.

Please note we have advised the speakers that it is their responsibility to disclose at the start of their presentation if they will be describing the use of a device, product, or drug that is not FDA approved or the off-label use of an approved device, product, or drug or unapproved usage.

The requirement for disclosure is not intended to imply any impropriety of such relationship, but simply to identify such relationships through full disclosure, and to allow the audience to form its own judgments regarding the presentation.